在糖尿病视网膜病变中通过孟德尔随机化发现和探索适应性免疫反应相关的药物标
Ning Gao1, Jingming Li1, Ting Wei1
1Department of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Diabetes research and clinical practice
|January 13, 2025
概括
这项研究确定了TRAV23DV6作为糖尿病视网膜病变 (DR) 的潜在药物标. 准这种基因可能为管理DR及其相关免疫反应提供新的治疗策略.
科学领域:
- 免疫基因组学是什么
- 眼科医生 眼科 眼科
- 药物基因组学 药物基因组学
背景情况:
- 持续的糖尿病增加了糖尿病视网膜病变 (DR) 的风险,这是视力丧失的主要原因.
- 目前DR的管理策略有限,需要确定新的治疗点.
研究的目的:
- 通过分析适应性免疫反应相关基因 (AIR-RG) 来确定糖尿病视网膜病变 (DR) 的潜在药物标.
- 调查已识别的基因在DR病变发生中的作用及其作为治疗点的潜力.
主要方法:
- 利用GSE102485数据集进行DR中的AIR-RG的转录组分析.
- 采用孟德尔随机化 (MR) 和施泰格测试来确定AIR-RG和DR之间的因果关系.
- 进行贝叶斯共定位分析以精确确定DR药物标和检测潜在副作用的表型扫描.
- 进行功能丰富和免疫透分析,以阐明DR中确定的目标的机制.
主要成果:
- 确定了27个与DR相关的AIR-RG,其中TRAV23DV6被确定为一个重要的风险因素.
- 通过同定位分析证实TRAV23DV6是潜在的DR药物标.
- 现型扫描显示了针对TRAV23DV6的潜在副作用,包括肝细胞癌和血栓栓塞.
- 发现TRAV23DV6参与了适应性免疫和抗原结合,其表达与DR中的免疫细胞透和激活有关.
结论:
- TRAV23DV6是糖尿病视网膜病变 (DR) 的有希望的药物标.
- 向TRAV23DV6为DR治疗提供了一个新的治疗途径,可能调节免疫反应.
- 需要进一步的研究来探索针对DR的TRAV23DV6治疗疗效和安全性.
相关概念视频
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...